Laurel Wealth Advisors (California)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$228K Buy
+4,934
New +$214K 0.02% 592
2022
Q2
Sell
-4,648
Closed -$206K 666
2022
Q1
$206K Sell
4,648
-872
-16% -$37.8K 0.02% 715
2021
Q4
$234K Buy
+5,520
New +$232K 0.02% 702
2019
Q3
Sell
-5,453
Closed -$234K 440
2019
Q2
$234K Sell
5,453
-1,010
-16% -$38.8K 0.05% 354
2019
Q1
$248K Buy
+6,463
New +$247K 0.06% 327

Other funds holding BSX

Laurel Wealth Advisors (California)'s BSX Position: Q4 2022 in Review

Laurel Wealth Advisors (California) opened a new position in Boston Scientific (BSX) in Q4 2022: 4,934 shares worth $228K. The stake represents 0.02% of the portfolio and ranks #592 among its holdings. This is a return to the name: Laurel Wealth Advisors (California) previously reported a position in BSX as recently as Q1 2022.

Laurel Wealth Advisors (California) first reported a position in BSX in Q1 2019 and has held it in 5 quarters since. The position peaked at $248K in Q1 2019. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Laurel Wealth Advisors (California) held 4,934 shares of Boston Scientific worth $228K as of Q4 2022.
  • Boston Scientific was a new Laurel Wealth Advisors (California) position in Q4 2022.
  • Boston Scientific made up 0.02% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #592 holding.
  • Laurel Wealth Advisors (California) first reported a position in Boston Scientific in Q1 2019 and has held it in 5 quarters since.
  • Laurel Wealth Advisors (California)'s Boston Scientific position peaked at $248K in Q1 2019.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.